Chiasma's IPO

Chiasma raised a round of funding on July 16, 2015. Investors include Public.

Chiasma (NASDAQ: CHMA) is a biopharmaceutical company dedicated to improving the lives of patients with rare diseases by developing and commercializing oral medications that were previously available …

Articles about Chiasma's IPO: